TORC polynucleotides and polypeptides, and methods of use

Details for Australian Patent Application No. 2005336514 (hide)

Owner Novartis AG

Inventors Bittinger, Mark; Labow, Mark Aron

Agent Davies Collison Cave

Pub. Number AU-A-2005336514

PCT Pub. Number WO2007/040550

Filing date 24 October 2005

Wipo publication date 17 May 2007

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

Event Publications

17 May 2007 Application Open to Public Inspection

  Published as AU-A-2005336514

17 May 2007 PCT application entered the National Phase

  PCT publication WO2007/040550 Priority application(s): WO2007/040550

11 December 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name Novartis AG, Application No. 2005336514, Under INID (43), correct the date to 12 April 2007

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005336519-Method of treating pulmonary disease with interferons

2005336513-Thiazolyl mGluR5 antagonists and methods for their use